MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

INTRODUCTION: Two phase 3 studies in adolescents and young adults demonstrated that MenB-FHbp, a meningococcal serogroup B (MenB) vaccine, elicits protective immune responses after 2 or 3 doses based on serum bactericidal antibody assays using human complement (hSBA) against 4 primary and 10 additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeslaar, Johannes, Absalon, Judith, Anderson, Annaliesa S., Eiden, Joseph J., Balmer, Paul, Harris, Shannon L., Jones, Thomas R., O’Neill, Robert E., Pregaldien, Jean-Louis, Radley, David, Maansson, Roger, Ginis, John, Srivastava, Amit, Perez, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452968/
https://www.ncbi.nlm.nih.gov/pubmed/32700260
http://dx.doi.org/10.1007/s40121-020-00319-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452968/
https://www.ncbi.nlm.nih.gov/pubmed/32700260
http://dx.doi.org/10.1007/s40121-020-00319-0

Ejemplares similares